奥美医疗（002950）8月18日主力资金净卖出431.96万元

Core Viewpoint - As of August 18, 2025, Aomei Medical (002950) closed at 9.67 yuan, down 1.02%, with a trading volume of 90,500 lots and a transaction value of 87.917 million yuan [1] Group 1: Financial Performance - Aomei Medical's Q1 2025 report shows a main revenue of 759 million yuan, a year-on-year increase of 1.64% [2] - The net profit attributable to shareholders is 86.503 million yuan, a year-on-year decrease of 7.86% [2] - The net profit after deducting non-recurring gains and losses is 74.065 million yuan, a year-on-year decrease of 11.39% [2] - The company's debt ratio stands at 32.54% [2] - The gross profit margin is 30.52% [2] Group 2: Market Position and Ratios - Aomei Medical's total market value is 6.124 billion yuan, compared to the industry average of 12.121 billion yuan, ranking 60th out of 123 [2] - The company's net assets are 3.526 billion yuan, while the industry average is 3.9 billion yuan, ranking 43rd out of 123 [2] - The price-to-earnings ratio (P/E) is 17.7, significantly lower than the industry average of 78.16, ranking 8th out of 123 [2] - The price-to-book ratio (P/B) is 1.76, compared to the industry average of 4.05, ranking 26th out of 123 [2] - The company's net profit margin is 11.42%, slightly above the industry average of 10.86%, ranking 66th out of 123 [2] - Return on equity (ROE) is 2.51%, compared to the industry average of 1.25%, ranking 31st out of 123 [2] Group 3: Capital Flow Analysis - On August 18, 2025, the net outflow of main funds was 4.3196 million yuan, accounting for 4.91% of the total transaction value [1] - The net inflow of speculative funds was 6.1971 million yuan, accounting for 7.05% of the total transaction value [1] - Retail investors experienced a net outflow of 1.8775 million yuan, accounting for 2.14% of the total transaction value [1]